The US Food and Drug Administration will consider within months emergency use authorization of the Pfizer/BioNTech's coronavirus vaccine in children 2 to 11 years old - at a time polls show younger Americans are least likely to say they want a shot. The move comes as the country's daily Covid-19 cases and deaths are now about one-fifth of what they […]
